KKR to Buy Integer Holdings for $4.3 Billion — 2nd Update

By Colin Kellaher


Investment firm KKR has struck a deal to acquire medical-device outsourcing company Integer Holdings for about $4.3 billion in cash.

KKR will pay $127 a share for Integer, the companies said Monday, a 4.8% premium to Friday's closing price of $121.21 for the Plano, Texas, company and some 52% above Integer's closing price of $83.67 on April 29, the day before the company put itself up for sale.

Shares of Integer were recently changing hands at $124.49, up 2.7%.The Wall Street Journal on Friday reported that New York-based KKR was closing in on a deal to take Integer private, sending the company's shares up 20% late in the session.

The deal, which carries an enterprise value of roughly $5.7 billion, is slated to close by the end of the year.

Analysts at KeyBanc Capital Markets said they view the KKR deal as a reasonable valuation and overall constructive outcome for Integer's shareholders in light of recent volatility and expected near-term headwinds.

Integer in late April said it was considering a potential sale or merger after cutting its full-year sales and earnings guidance.

The company in March reached a cooperation agreement with activist investor Irenic Capital Management, which had built a stake of more than 3% and late last year urged the company to refresh its board and consider a sale.

KKR, which has around $800 billion in assets under management, said it is investing in Integer through its core private-equity strategy, adding that it plans to finance the transaction through a combination of equity provided by the firm's investment funds and committed debt financing.


Write to Colin Kellaher at colin.kellaher@wsj.com


(END) Dow Jones Newswires

August 03, 2026 10:57 ET (14:57 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

Sponsor Center